Emergency Preparedness Training for Dementia Caregiving
(DPW-Caregiver Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help caregivers of people with dementia prepare for emergencies like pandemics and extreme weather. Participants will either receive a personalized emergency preparedness program, Disaster PrepWise, with guidance from a trained volunteer, or printed information on disaster readiness. The trial will measure how these approaches impact caregiver resilience, stress, and preparedness. It is ideal for English-speaking family members or friends caring for someone with dementia who lives at home, not in a nursing facility.
As an unphased trial, this study offers a unique opportunity to contribute to valuable research that can enhance emergency preparedness for caregivers.
Will I have to stop taking my current medications?
The trial protocol does not specify whether participants must stop taking their current medications.
What prior data suggests that the Disaster PrepWise program is safe for caregivers?
Research shows that the Disaster PrepWise-Caregiver program helps caregivers of people with dementia prepare for emergencies. Early results suggest that this program is safe and aids caregivers in making emergency plans and building support networks. As a training program rather than a medical treatment, it poses no known physical risks or side effects. Previous testing demonstrated improved preparedness without any reported safety issues.12345
Why are researchers excited about this trial?
Researchers are excited about the Disaster PrepWise-Caregiver program because it offers a hands-on approach to emergency preparedness specifically tailored for dementia caregivers. Unlike the standard handout guides from organizations like the Alzheimer's Association, this program involves a trained interventionist who helps develop a personalized household emergency management plan. This direct and personalized engagement could empower caregivers to better manage emergencies, potentially leading to improved outcomes for both caregivers and those with dementia during disasters.
What evidence suggests that the Disaster PrepWise program is effective for improving emergency preparedness in dementia caregiving?
Research has shown that the Disaster PrepWise (DPW) program, which participants in this trial may receive, is designed to help caregivers of people with dementia prepare for emergencies. This program offers personalized advice to create emergency plans and build support networks. Studies have found that supporting caregivers in this way can reduce their stress and delay the need to move a person with dementia into a care facility. This approach can make caregivers more resilient and better prepared to handle disasters. Early results suggest that this personalized support can lead to better outcomes for caregivers, making them feel more capable and supported.12346
Who Is on the Research Team?
Sato Ashida, PhD
Principal Investigator
University of Iowa
Are You a Good Fit for This Trial?
This trial is for English-speaking adults who are family members or friends caring for someone with Alzheimer's disease or related dementias (ADRD). Caregivers can participate regardless of living situation with the individual. Excluded are caregivers of those in early stages like predementia, those in nursing homes, and anyone unable to consent or respond due to their own conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete a baseline survey before randomization
Intervention
Caregivers in the intervention group receive the Disaster PrepWise program, while control participants receive a handout on emergency preparedness
Follow-up
Participants complete follow-up surveys to assess changes in stress, resilience, self-efficacy, preparedness, and social networks
What Are the Treatments Tested in This Trial?
Interventions
- Disaster PrepWise-Caregiver
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sato Ashida
Lead Sponsor
National Institute on Aging (NIA)
Collaborator